• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 5th February 2013

EQ-5D Index Clustering: Causes and Implications for Health Care

In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined what may cause the two-cluster shape of EQ-5D indexes. This is important because these…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Measuring patients' outcomes using E!-5D

In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined what may cause the two-cluster shape of EQ-5D indexes. This is important because these indexes are used widely in other analyses that affect health care resource decisions.

Measuring patients' outcomes using E!-5D

In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined what may cause the two-cluster shape of EQ-5D indexes. This is important because these indexes are used widely in other analyses that affect health care resource decisions.

The EQ-5D is used widely in economic analyses, population health surveys and, more recently, for routine assessment of patients’ health — for example, in the NHS Patient Reported Outcome Measures (PROMs) programme. The EQ-5D instrument comprises two elements that ask the patient to report health. The first is the EQ-5D self-classifier, where respondents create a “health profile” by ticking boxes to indicate which of three levels of problems (none, some or extreme) they have on each of five dimensions (mobility, self care, usual activities, pain and discomfort, and anxiety and depression). The second is the EQ-VAS, where respondents rate their overall health on a visual analogue scale from 0 (worst health imaginable) to 100 (best health imaginable). Both provide valuable data and both are used in evaluations of health services and decisions about health care allocation.

The most common way of analysing data from the EQ-5D is to use index values that summarise the profile data. Such indexes are used widely, serving as the bases for a range of other important statistical analyses and modelling. Their reliability and appropriate use, then, both are crucial.

The focus of this paper is on the tendency of EQ-5D index values to cluster into two groups. It has not been clear whether this phenomenon in fact represents two distinct patient groups or is an artefact of the methods used to weight the profile data to produce indexes. To gain insight into this issue, the authors analysed data from the English NHS PROMs programme (hip and knee replacements, and varicose vein and hernia repairs) and from a study of two chronic conditions (asthma and angina). The distribution of EQ-5D index values was compared with distributions from data that are not weighted; the ungrouped profile data were used to determine whether and how their characteristics might affect the distribution. The EQ-5D index values also were compared to distributions both from condition-specific indexes for the same kinds of patients and from the EQ-VAS.

The authors conclude that the underlying profile data and the weighting system each affect the observed two-cluster distribution. The EQ-5D classification system captures differences between patients with the same condition on dimensions that are observed mainly at level 2 or 3. The weights commonly used to calculate the index exacerbate this by placing greater weight on level 3 observations, creating a noticeable gap in index values between the groups.

As the authors note, the analyses in the paper highlight the important point that any index “in effect obscures useful information about health states and may even produce misleading information”. They recommend that all the underlying data for all health indexes, not just the EQ-5D, be well understood and that health indexes be used with care.

Parkin, D., Devlin, N. and Feng, Y. (2013) What determines the shape of an EQ-5D index distribution? Paper presented at the Health Economists Study Group meeting. Exeter, UK. 9-11 January 2013.

For additional information, please contact Nancy Devlin.

For an overview of OHE’s extensive work on patient-reported outcomes measures, including the EQ-5D and the EQ-VAS, click here.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes

Related News

Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!